NCT01694264 Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα Status TERMINATED Phase PHASE3
NCT01692457 A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Status WITHDRAWN Phase N/A
NCT01690299 Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01680159 A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis Status COMPLETED Phase PHASE3
NCT01559038 Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis Status COMPLETED Phase N/A
NCT01474876 Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Status COMPLETED Phase N/A
NCT01392326 Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT01316224 Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment Status COMPLETED Phase N/A
NCT01307423 Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT01282372 Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab Status COMPLETED Phase N/A
NCT01273519 Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab Status COMPLETED Phase N/A
NCT01212770 PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01212757 PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01198509 Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) Status COMPLETED Phase NA
NCT01172938 Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01169844 Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care Status COMPLETED Phase N/A